Duke University granted BioMimetix an exclusive license to develop a class of patented compounds to treat radiation toxicity incurred during the treatment of cancer

Duke University

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

BioMimetix Pharmaceutical Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced